BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23829783)

  • 1. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.
    Xiao Q; Li Q; Zhang B; Yu W
    Pediatr Surg Int; 2013 Jun; 29(6):575-81. PubMed ID: 23519547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the optimal time to discontinue propranolol treatment in infantile hemangiomas: A prospective study.
    Wang L; Wang W; Zhou Z; Li J; Li Z; Lv R; Xu G; Bi J; Huo R
    J Am Acad Dermatol; 2024 Apr; 90(4):783-789. PubMed ID: 38159645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.
    Castaneda S; Melendez-Lopez S; Garcia E; De la Cruz H; Sanchez-Palacio J
    Adv Ther; 2016 Oct; 33(10):1831-1839. PubMed ID: 27461120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile hemangiomas: risk factors for complications, recurrence and unaesthetic sequelae.
    Mariani LG; Ferreira LM; Rovaris DL; Bonamigo RR; Kiszewski AE
    An Bras Dermatol; 2022; 97(1):37-44. PubMed ID: 34848114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations.
    Del Frari L; Léauté-Labrèze C; Guibaud L; Barbarot S; Lacour JP; Chaumont C; Delarue A; Voisard JJ; Brunner V
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00399. PubMed ID: 29736244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical surgical technique using the SMISS approach for lip reduction in involuted lip infantile hemangiomas.
    Chen Q; Chang SJ; Gao W; Chang L; Qiu Y; Lin X
    BMC Pediatr; 2024 May; 24(1):368. PubMed ID: 38807073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole Oral Solution for Infantile Complicated Hemangioma with Double Lesions on the Skin and One Inside the Liver.
    He X; Ran X; Liang D; Fan H; Ran Y
    Clin Cosmet Investig Dermatol; 2024; 17():1217-1226. PubMed ID: 38803817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regimen for accelerated propranolol initial dosing (RAPID).
    Huang CY; Perman MJ; Yan AC
    Pediatr Dermatol; 2024 Apr; ():. PubMed ID: 38631683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large, ulcerated infantile hemangioma of the chest wall complicated by life-threatening hemorrhage: Case report and literature review.
    Dong E; Rodriguez ED; Levin CI; Gardner GC; Metry DW
    Pediatr Dermatol; 2024 Apr; ():. PubMed ID: 38627999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal infantile hemangioma: A rare cause of digestive tract bleeding in children to consider.
    Cura-Esquivel I; Velasquez-Palacios C; Núñez-Ku M
    Clin Case Rep; 2021 Sep; 9(9):e04722. PubMed ID: 34504695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese clinical practice guidelines for vascular anomalies 2017.
    Mimura H; Akita S; Fujino A; Jinnin M; Ozaki M; Osuga K; Nakaoka H; Morii E; Kuramochi A; Aoki Y; Arai Y; Aramaki N; Inoue M; Iwashina Y; Iwanaka T; Ueno S; Umezawa A; Ozeki M; Ochi J; Kinoshita Y; Kurita M; Seike S; Takakura N; Takahashi M; Tachibana T; Chuman K; Nagata S; Narushima M; Niimi Y; Nosaka S; Nozaki T; Hashimoto K; Hayashi A; Hirakawa S; Fujikawa A; Hori Y; Matsuoka K; Mori H; Yamamoto Y; Yuzuriha S; Rikihisa N; Watanabe S; Watanabe S; Kuroda T; Sugawara S; Ishikawa K; Sasaki S
    Jpn J Radiol; 2020 Apr; 38(4):287-342. PubMed ID: 32207066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese clinical practice guidelines for vascular anomalies 2017.
    Mimura H; Akita S; Fujino A; Jinnin M; Ozaki M; Osuga K; Nakaoka H; Morii E; Kuramochi A; Aoki Y; Arai Y; Aramaki N; Inoue M; Iwashina Y; Iwanaka T; Ueno S; Umezawa A; Ozeki M; Ochi J; Kinoshita Y; Kurita M; Seike S; Takakura N; Takahashi M; Tachibana T; Chuman K; Nagata S; Narushima M; Niimi Y; Nosaka S; Nozaki T; Hashimoto K; Hayashi A; Hirakawa S; Fujikawa A; Hori Y; Matsuoka K; Mori H; Yamamoto Y; Yuzuriha S; Rikihisa N; Watanabe S; Watanabe S; Kuroda T; Sugawara S; Ishikawa K; Sasaki S
    Pediatr Int; 2020 Mar; 62(3):257-304. PubMed ID: 32202048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.
    Mimura H; Akita S; Fujino A; Jinnin M; Ozaki M; Osuga K; Nakaoka H; Morii E; Kuramochi A; Aoki Y; Arai Y; Aramaki N; Inoue M; Iwashina Y; Iwanaka T; Ueno S; Umezawa A; Ozeki M; Ochi J; Kinoshita Y; Kurita M; Seike S; Takakura N; Takahashi M; Tachibana T; Chuman K; Nagata S; Narushima M; Niimi Y; Nosaka S; Nozaki T; Hashimoto K; Hayashi A; Hirakawa S; Fujikawa A; Hori Y; Matsuoka K; Mori H; Yamamoto Y; Yuzuriha S; Rikihisa N; Watanabe S; Watanabe S; Kuroda T; Sugawara S; Ishikawa K; Sasaki S
    J Dermatol; 2020 May; 47(5):e138-e183. PubMed ID: 32200557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol induces hemangioma endothelial cell apoptosis via a p53‑BAX mediated pathway.
    Yao TH; Pataer P; Regmi KP; Gu XW; Li QY; Du JT; Ge SM; Tu JB
    Mol Med Rep; 2018 Jul; 18(1):684-694. PubMed ID: 29767244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminary report.
    Furuta S; Sato H; Tsuji S; Murakami F; Kitagawa H
    Pediatr Surg Int; 2016 Sep; 32(9):857-62. PubMed ID: 27461431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing face of complicated infantile hemangioma treatment.
    Menapace D; Mitkov M; Towbin R; Hogeling M
    Pediatr Radiol; 2016 Oct; 46(11):1494-506. PubMed ID: 27450406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of Oral Propranolol versus Other Treatments for Infantile Hemangiomas: A Meta-Analysis.
    Liu X; Qu X; Zheng J; Zhang L
    PLoS One; 2015; 10(9):e0138100. PubMed ID: 26375455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages Contribute to the Progression of Infantile Hemangioma by Regulating the Proliferation and Differentiation of Hemangioma Stem Cells.
    Zhang W; Chen G; Wang FQ; Ren JG; Zhu JY; Cai Y; Zhao JH; Jia J; Zhao YF
    J Invest Dermatol; 2015 Dec; 135(12):3163-3172. PubMed ID: 26288359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta blockers: an innovation in the treatment of infantile hemangiomas.
    Admani S; Feldstein S; Gonzalez EM; Friedlander SF
    J Clin Aesthet Dermatol; 2014 Jul; 7(7):37-45. PubMed ID: 25053982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.